Melinta Therapeutics, Inc. (NASDAQ:MLNT)

BATS BZX Real-Time Price
As of 3:39pm ET
 +0.025 / +0.32%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Melinta Therapeutics, Inc. have a median target of 10.00, with a high estimate of 21.00 and a low estimate of 8.00. The median estimate represents a +26.18% increase from the last price of 7.93.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Hold stock in Melinta Therapeutics, Inc.. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -29.47%
Growthannually 78.12%


Growthquarterly 5.28%
Growthannually 98.83%
Key to the earnings and sales forecast charts.